These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 14092126)

  • 1. [ACTION OF DIFFERENT INHIBITORS OF L-DOPA-5-HTP DECARBOXYLASE ON AN INDUCED HYPERTHERMIA OF CENTRAL ORIGIN].
    HELBECQUE C; JUILLARD AM; HEROLD M; CAHN J
    C R Seances Soc Biol Fil; 1963 Oct; 157():996-9. PubMed ID: 14092126
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACTION OF CERTAIN L-DOPA/5-HTP DECARBOXYLASE INHIBITORS ON HYPOTHALAMO-HYPOPHYIAL NEUROSECRETION IN THE RAT].
    SOULAIRAC A; SOULAIRAC ML
    C R Seances Soc Biol Fil; 1964; 158():1445-7. PubMed ID: 14250544
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacology of several aromatic amino acid decarboxylase inhibitors].
    Uspenskiĭ AE; Dabagov NS; Skoldinov AP
    Biull Eksp Biol Med; 1978 Oct; 86(10):444-7. PubMed ID: 309344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [L-DOPA/5HTP DECARBOXYLASE INHIBITORS: PHARMACOLOGICAL PROPERTIES. THERAPEUTIC INDICATIONS].
    CAHN J; HEROLD M
    Agressologie; 1963; 11():375-84. PubMed ID: 14087222
    [No Abstract]   [Full Text] [Related]  

  • 5. Presence of endogenous inhibitor of aromatic L-amino acid decarboxylase in monkey serum.
    Rahman MK; Togari A; Kojima K; Takahashi K; Nagatsu T
    Mol Cell Biochem; 1984 Aug; 63(1):53-8. PubMed ID: 6333583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. THE DIRECT DEMONSTRATION OF A BARRIER MECHANISM IN THE BRAIN CAPILLARIES.
    BERTLER A; FALCK B; ROSENGREN E
    Acta Pharmacol Toxicol (Copenh); 1963; 20():317-21. PubMed ID: 14162814
    [No Abstract]   [Full Text] [Related]  

  • 7. [ACTION OF 5-HTP/DOPA DECARBOXYLASE INHIBITORS ON DIURESIS, URINARY ELECTROLYTES AND RELEASE OF THE ANTIDIURETIC HORMONE].
    CAHN J; HEROLD M; BARRE N
    C R Seances Soc Biol Fil; 1964; 158():1331-5. PubMed ID: 14210566
    [No Abstract]   [Full Text] [Related]  

  • 8. 5-Hydroxy-tryptophan for the treatment of L-DOPA-induced dyskinesia in the rat Parkinson's disease model.
    Tronci E; Lisci C; Stancampiano R; Fidalgo C; Collu M; Devoto P; Carta M
    Neurobiol Dis; 2013 Dec; 60():108-14. PubMed ID: 24004632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [COMPARATIVE ACTION OF 2 DECARBOXYLASE INHIBITORS ON THE METABOLISM OF ENDOGENOUS AND EXOGENOUS 5-HYDROXYTRYPTAMINE].
    KUNZ E
    Arch Int Pharmacodyn Ther; 1964 Jan; 147():1-8. PubMed ID: 14116929
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE ROLE OF CATECHOLAMINES IN THE CONTROL OF HYPOTHALAMIC NEUROSECRETION. EFFECTS OF RESERPINE, A MONOAMINE OXIDASE INHIBITOR AND DIFFERENT D-1 DOPA 5-HTP DECARBOXYLASE INHIBITORS].
    SOULAIRAC A; SOULAIRAC ML
    Agressologie; 1964; 5():465-71. PubMed ID: 14192332
    [No Abstract]   [Full Text] [Related]  

  • 11. [THE ROLE OF CATECHOLAMINES IN THE CONTROL OF HYPOTHALAMIC NEUROSECRETION. EFFECTS OF RESERPINE COMPOUNDS, MONOAMINE OXIDASE INHIBITORS AND D-1 DOPA 5-HTP DECARBOXYLASE INHIBITORS].
    CAHN J; HEROLD M
    Agressologie; 1964; 5():451-63. PubMed ID: 14192331
    [No Abstract]   [Full Text] [Related]  

  • 12. [5-HYDROXYTRYPTOPHAN DOPA DECARBOXYLASE IN NERVOUS AND CARDIAC TISSUES IN THE MOLLUSC HELIX POMATIA. INTERACTION OF SUBSTRATES IN VITRO].
    CARDOT J
    C R Hebd Seances Acad Sci; 1964 Jul; 259():902-4. PubMed ID: 14190531
    [No Abstract]   [Full Text] [Related]  

  • 13. [EFFECT OF THE DOPA-DECARBOXYLASE INHIBITOR ALPHA-METHYLDOPA ON THE INCORPORATION OF DOPA INTO MELANIN AND PYROCATECHOLAMINE. IN VIVO STUDIES ON MELANOMA MICE WITH TRITIATED DOPA].
    HEMPEL K; DEIMEL M
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1963 Nov; 246():203-14. PubMed ID: 14095447
    [No Abstract]   [Full Text] [Related]  

  • 14. The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset.
    Tayarani-Binazir KA; Jackson MJ; Fisher R; Zoubiane G; Rose S; Jenner P
    Eur J Pharmacol; 2010 Jun; 635(1-3):109-16. PubMed ID: 20303948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DECARBOXYLASE ACTIVITIES IN TISSUES OF TRYPTOPHAN-DEFICIENT RATS.
    REID JD; SHEPHERD DM
    Biochim Biophys Acta; 1964 Mar; 81():560-4. PubMed ID: 14170326
    [No Abstract]   [Full Text] [Related]  

  • 16. Reaction of dopa decarboxylase with L-aromatic amino acids under aerobic and anaerobic conditions.
    Bertoldi M; Borri Voltattorni C
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):533-8. PubMed ID: 11085948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of L-DOPA on brain polysomes and protein synthesis: probable mediation by intracellular dopamine.
    Weiss BF; Roel LE; Munro HN; Wurtman RJ
    Adv Neurol; 1974; 5():87-99. PubMed ID: 4155238
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action of different inhibitors of L-DOPA decarboxylase on the water ration, diuresis and urinary sodium and potassium elimination in rats].
    BARRE N; CAHN J; HEROLD M
    C R Seances Soc Biol Fil; 1962; 156():1807-9. PubMed ID: 13969508
    [No Abstract]   [Full Text] [Related]  

  • 19. [THE EFFECT OF IPRONIAZID AND PHENYZINE OF 5-HYDOXYTRYPTOPHAN DECARBOXYLASE].
    UTESHEV BS
    Farmakol Toksikol; 1964; 27():293-5. PubMed ID: 14238785
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutation of cysteine 111 in Dopa decarboxylase leads to active site perturbation.
    Dominici P; Moore PS; Castellani S; Bertoldi M; Voltattorni CB
    Protein Sci; 1997 Sep; 6(9):2007-15. PubMed ID: 9300500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.